The vaccinia virus N1L ORF may encode a multifunctional protein possibly targeting different kinases, one of which influences ATP levels in vivo

Annals of the New York Academy of Sciences

Volumn 1056, Issue , 2005, Pages 87-99

  Abrahams, Melissa Rose ^a   Zhang, Zhouning ^b   Chien, Sufan ^b   Skerns, Tim ^a,c   Kotwal, Girish J ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b University of Louisville School of Medicine   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

13.8 kDa protein; ATP; Neurovirulence factor; Pathogenesis; Vaccinia virus

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATE; PHOSPHOTRANSFERASE; PROTEIN N1L; SOMATOMEDIN C RECEPTOR KINASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING SITE; BIOINFORMATICS; BRAIN INFECTION; CONFERENCE PAPER; CONTROLLED STUDY; DIMERIZATION; ENERGY METABOLISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOGENESIS; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; VACCINIA VIRUS;

EID: 29744460266     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1352.006     Document Type: Conference Paper

References (24)

1. KOTWAL, G.J. & B. Moss. 1988. Vaccinia virus encodes a secretary polypeptide structurally related to complement control proteins. Nature 355: 176-178.
2. BARTLETT, N., J.A. SYMONS, D.C. TSCHARKE & G.L. SMITH. 2002. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83: 1965-1976.
3. KOTWAL, G.J., A.W. HÜGEN & B. Moss. 1989. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 171: 579-587.
4. BILLINGS, B.B., S.A. SMITH, Z. ZHANG, et al. 2004. Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain. Ann. N.Y. Acad. Sci. 1030: 297-302.
5. SMITH, S.A. & G.J. KOTWAL. 2001. Virokines: novel immunomodulatory agents. Expert Opin. Biol. Ther. 1: 343-357.
6. DIPERNA, G., J. STACK, A.C. BOWIE, et al. 2004. Poxvirus protein N1L targets the I-B Kinase complex, inhibits signalling to NF-B by the tumor necrosis factor superfamily of receptors, and inhibits NF-B and IRF3 signalling by Toll-like receptors J. Biol. Chem. 279: 36570-36578.
7. th Ed. :442-462. W.H. Freeman & Co. New York.
8. BROYLES, S.S. 2003. Vaccinia virus transcription. J. Gen. Virol. 84: 2293-2303.
9. FENGER, T.W. 1984. Replication of DNA viruses. In Textbook of Human Virology. R.B. Belshe, Ed.: 49-78. PSG Publishing Co., Inc. Littleton, MA.
10. BAXBY, D. 1984. Poxviruses. In Textbook of Human Virology. R.B. Belshe, Ed.: 929-950. PSG Publishing Co., Inc. Littleton, MA.
11. GERSHOWITZ, A., R.F. BOONE & B. MOSS. 1978. Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (, -1mido) triphosphate. J. Virol. 27: 399-408.
12. MOSS, B. 2001. Poxviridae and their replication. In Virology. D.M. Knipe & P.M. Howley, Eds.: 2849-2883. Lippincott-Williams & Wilkins. Philadelphia.
13. AMES, A., III. 2000. CNS energy metabolism is related to function. Brain Res. Rev. 34: 42-68.
14. JOKLIK, W.K. 1962. The purification of four strains of poxvirus. Virology 18: 9-18.
15. STANNARD, L.M., D. MARIAS, D. KOW & K.R. DUMBELL. 1998. Evidence for incomplete replication of a penguin poxvirus in cells of mammalian origin. J. Gen. Virol. 79: 1637-1646.
16. NOTARI, L., M. ISODORO, C. CUGNOLI & A. MORELLI. 2001. Adenylate kinase activity in rod outer segments of bovine relina. Biochim. Biophys. Acta 1504: 438-443.
17. PISSAREK, M., R. REIHJARDT, C. REICHELT, et al. 1999. Rapid assay for one-run determination of purine and pyrimidine nucleotide contents in neocortical slices and cell cultures. Brain Res. Protocols 4: 314-321.
18. KHAN, H. 2003. Bioluminometric assay of ATP in mouse brain: determinant factors for enhanced test sensitivity. J. Biosci. 28: 379-382.
19. SANTOS, D.A., A.I. SALGADO & R.A. CUNHA. 2003. ATP is released from nerve terminals and from activated muscle fibres on stimulation of the rat phrenic nerve. Neurosci. Lett. 338: 225-228.
20. MUNSHI, S., D.L. HALL, M. KORNIENKO, et al. 2003. Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution. Acta Crystallogr. Sect. D Biol. Crystallogr. 59: 1725-1730.
21. PAUTSCH, A., A. ZOEPHEL, H. AHORN, et al. 2001. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 9: 955-965.
22. BERANEK, C.F., R. SHAFER, L. BOEOGA & N. HERSCHKOWITZ. 1982. Viral tropisms in mouse brain cell cultures. Med. Microbiol. Immunol. 170: 201-207.
23. SOEKAWA, M., C. MORITA, R. MORIGUCHI & M. NAKAMURA. 1974. Neurovirulence of vaccinia viruses for mice. Zentralbl. Bakteriol. Hyg. J. Abt. Orig. A. 226: 434-442.
24. BASERGA, R. 1999. The IGF-1 receptor in cancer research. Exp. Cell Res. 253: 1-6.